Related Experiment Videos
Plasma polyunsaturated fatty acids and the decline of renal function
Fulvio Lauretani1, Richard D Semba, Stefania Bandinelli
1Tuscany Regional Agency, Florence, Italy.
Clinical Chemistry
|January 19, 2008
Summary
Higher intake of polyunsaturated fatty acids (PUFAs) is linked to better kidney function in older adults. These essential fats, including omega-3 and omega-6, may protect against age-related decline in renal function.
Area of Science:
- Gerontology
- Nutritional Science
- Nephrology
Background:
- Emerging evidence suggests a connection between polyunsaturated fatty acids (PUFAs) and chronic kidney disease development.
- Investigating the role of PUFAs in maintaining renal function in aging populations is crucial for public health.
Purpose of the Study:
- To investigate the association between plasma polyunsaturated fatty acids (PUFAs) and renal function in adults aged 65 and older.
- To determine if PUFA levels predict the decline in kidney function over a 3-year period.
Main Methods:
- Cross-sectional and prospective analysis of 931 older adults from the InCHIANTI study.
- Measurement of plasma PUFAs at baseline and estimation of creatinine clearance using the Cockcroft-Gault equation at baseline and 3-year follow-up.
Main Results:
- Higher baseline concentrations of total plasma PUFAs, n-3 fatty acids (FA), and n-6 FA were associated with better renal function (higher creatinine clearance).
- Baseline levels of total plasma PUFAs, n-3 FA, and specific FAs (linoleic, linolenic, arachidonic) independently predicted a slower decline in creatinine clearance over 3 years.
- Higher plasma PUFA levels at enrollment were linked to a reduced risk of developing renal insufficiency during the follow-up period.
Conclusions:
- Elevated concentrations of both n-3 and n-6 PUFAs may help to mitigate the age-related decline in kidney function.
- These findings suggest a potential protective role for PUFAs in maintaining renal health in older adults.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:29Drug Distribution: Plasma Protein Binding
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...